Researchers design ‘prodrug’ that targets cancer cells’ big appetite for glutamine, leaving healthy cells unharmed
Researchers have revamped an anti-cancer drug to better target cancer cells and leave healthy tissues unharmed.
Materials provided by Johns Hopkins Medicine. Note: Content may be edited for style and length.
Source link aaaaa